Clinical Trial Update: Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update comparing first-line polychemotherapy alone to polychemotherapy plus PIPAC for gastric cancer, with patient recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: Nizhny Novgorod Regional Clinical Oncology Center | Conditions: Gastric Cancer | Phase 2 | Status: RECRUITING